Details for: NBPF26

Gene ID: 101060684

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: NBPF26

Ensembl ID: ENSG00000273136

Description: NBPF member 26

Cell Significance Landscape

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • plasmablast CL0000980
    CSI 11.66
    rCSI 9.18%
    PRS 90.12
  • stromal cell CL0000499
    CSI 7.19
    rCSI 20.21%
    PRS 82.18
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 6.34
    rCSI 4.27%
    PRS 96.04
  • conventional dendritic cell CL0000990
    CSI 5.95
    rCSI 4.97%
    PRS 83.33
  • BEST4+ enteroycte CL4030026
    CSI 4.72
    rCSI 5.87%
    PRS 86.94
  • mature B cell CL0000785
    CSI 4.69
    rCSI 4.08%
    PRS 93.71
  • naive B cell CL0000788
    CSI 4.48
    rCSI 3.84%
    PRS 90.89
  • unswitched memory B cell CL0000970
    CSI 4.27
    rCSI 3.6%
    PRS 95.76
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 4.21
    rCSI 3.02%
    PRS 96.01
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 3.83
    rCSI 2.87%
    PRS 96.7
  • class switched memory B cell CL0000972
    CSI 3.69
    rCSI 2.76%
    PRS 94.95
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 3.4
    rCSI 2.39%
    PRS 95.14
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 3.36
    rCSI 1.98%
    PRS 97.32
  • immature B cell CL0000816
    CSI 3.29
    rCSI 2.45%
    PRS 94.17
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 3.28
    rCSI 2.19%
    PRS 93.89
  • fibroblast of lung CL0002553
    CSI 3.27
    rCSI 3.05%
    PRS 87.82
  • melanocyte CL0000148
    CSI 3.25
    rCSI 2.41%
    PRS 81.99
  • T follicular helper cell CL0002038
    CSI 3.07
    rCSI 2.3%
    PRS 95.54
  • suprabasal keratinocyte CL4033013
    CSI 3
    rCSI 4.91%
    PRS 55.63
  • secretory cell CL0000151
    CSI 2.94
    rCSI 3.07%
    PRS 85.81
  • mature NK T cell CL0000814
    CSI 2.8
    rCSI 3.59%
    PRS 92.05
  • bronchus fibroblast of lung CL2000093
    CSI 2.73
    rCSI 2.22%
    PRS 86.32
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.48
    rCSI 1.93%
    PRS 89.79
  • CD14-positive monocyte CL0001054
    CSI 2.35
    rCSI 2.92%
    PRS 93.3
  • alveolar macrophage CL0000583
    CSI 2.33
    rCSI 3.83%
    PRS 89.43
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 2.31
    rCSI 1.78%
    PRS 89.86
  • elicited macrophage CL0000861
    CSI 2.26
    rCSI 2.08%
    PRS 92.34
  • non-classical monocyte CL0000875
    CSI 2.25
    rCSI 3.61%
    PRS 92.85
  • intermediate monocyte CL0002393
    CSI 2.14
    rCSI 3.24%
    PRS 91.22
  • enteric smooth muscle cell CL0002504
    CSI 2.08
    rCSI 2.97%
    PRS 87.19
  • chondrocyte CL0000138
    CSI 1.9
    rCSI 3.02%
    PRS 81.26
  • Mueller cell CL0000636
    CSI 1.87
    rCSI 4.28%
    PRS 79.43
  • lung secretory cell CL1000272
    CSI 1.87
    rCSI 4.62%
    PRS 87.13
  • conjunctival epithelial cell CL1000432
    CSI 1.85
    rCSI 2.83%
    PRS 86.47
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.61
    rCSI 8.09%
    PRS 95.23
  • choroid plexus epithelial cell CL0000706
    CSI 1.58
    rCSI 2.58%
    PRS 78.23
  • cardiac neuron CL0010022
    CSI 1.56
    rCSI 5%
    PRS 84.91
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.37
    rCSI 1.66%
    PRS 92.49
  • alveolar adventitial fibroblast CL4028006
    CSI 1.34
    rCSI 2.11%
    PRS 87.75
  • helper T cell CL0000912
    CSI 1.2
    rCSI 1.69%
    PRS 83.72
  • melanocyte of skin CL1000458
    CSI 1.07
    rCSI 1.45%
    PRS 55.71
  • basal cell of epidermis CL0002187
    CSI 1.01
    rCSI 1.8%
    PRS 56.79
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 0.71
    rCSI 0.86%
    PRS 67.21
  • blood vessel smooth muscle cell CL0019018
    CSI 0.36
    rCSI 2.95%
    PRS 82.67

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [NBPF26](/details-gene/101060684) is a protein-coding gene located on chromosome 1p11.2 and a member of the Neuroblastoma Breakpoint Family (NBPF). Functional annotations suggest it is a cytoplasmic protein involved in calcium ion binding ([GO:0005509](https://www.ebi.ac.uk/QuickGO/term/GO:0005509)). **Overall**, expression data reveals a highly significant role for [NBPF26](/details-gene/101060684) within the immune system, particularly in the lymphoid lineage. It is most prominently expressed in [plasmablasts](/details-cell/CL0000980) and shows strong enrichment across various stages of B and T cell maturation and activation, indicating a key function in adaptive immunity. ## Cellular Roles and Expression Landscape The expression profile of [NBPF26](/details-gene/101060684) strongly implicates it as a key component of the adaptive immune system. Its significance is most pronounced in the B-cell lineage, with the highest Cell Significance Index (CSI) observed in [plasmablasts](/details-cell/CL0000980) (CSI: 11.66), the precursors to antibody-secreting plasma cells. The gene's consistent expression across various B-cell differentiation stages, including [naive B cells](/details-cell/CL0000788), multiple memory B-cell subsets, and [immature B cells](/details-cell/CL0000816), suggests a continuous role throughout B-cell development and the humoral immune response. In addition to its prominence in B-cells, [NBPF26](/details-gene/101060684) is also significantly expressed in multiple T-lymphocyte populations. These include both cytotoxic and helper T-cell subsets, such as [central memory CD8-positive, alpha-beta T cells](/details-cell/CL0000907) and [central memory CD4-positive, alpha-beta T cells](/details-cell/CL0000904), as well as naive T-cells. This broad expression pattern suggests a shared function in the biology of both major lymphocyte arms. The gene's role in immunity is further supported by its notable expression in antigen-presenting [conventional dendritic cells](/details-cell/CL0000990) and both major subsets of human natural killer cells. Interestingly, [NBPF26](/details-gene/101060684) also shows significant expression in non-lymphoid cell types, including [stromal cells](/details-cell/CL0000499) and [BEST4+ enterocytes](/details-cell/CL4030026). Its presence in [stromal cells](/details-cell/CL0000499), which provide structural and signaling support in lymphoid organs, may point to a role in the tissue microenvironment that orchestrates immune responses. ## Pathways and Molecular Function Based on Gene Ontology annotations, [NBPF26](/details-gene/101060684) functions as a calcium ion binding protein ([GO:0005509](https://www.ebi.ac.uk/QuickGO/term/GO:0005509)) located within the cytoplasm ([GO:0005737](https://www.ebi.ac.uk/QuickGO/term/GO:0005737)). Calcium signaling is a fundamental and ubiquitous second messenger system that is critical for lymphocyte function. In both B and T cells, fluctuations in intracellular calcium concentration are essential for triggering activation, proliferation, differentiation, and effector functions following antigen recognition. The high expression of [NBPF26](/details-gene/101060684) in activated lymphocyte populations, especially [plasmablasts](/details-cell/CL0000980), is consistent with a role in modulating these calcium-dependent signaling cascades, potentially by buffering calcium levels or acting as a calcium-dependent sensor that interfaces with downstream pathways. ## Research Directions The specific role of [NBPF26](/details-gene/101060684) in the immune system remains to be elucidated. Its strong association with terminal B-cell differentiation and its annotated calcium-binding function provide a clear basis for further investigation. **Proposed Hypotheses:** 1. Given its peak expression in [plasmablasts](/details-cell/CL0000980), [NBPF26](/details-gene/101060684) is a critical modulator of the terminal differentiation of B-cells into antibody-secreting cells. It may function by regulating the activity of calcium-dependent transcription factors, such as NFAT, which are essential for this process. 2. The significant expression in [stromal cells](/details-cell/CL0000499) suggests that [NBPF26](/details-gene/101060684) mediates calcium-dependent signaling within the lymphoid tissue microenvironment, potentially influencing lymphocyte survival, trafficking, or activation through interactions with immune cells. **Suggested Experimental Approach:** To test the hypothesis that [NBPF26](/details-gene/101060684) is essential for B-cell differentiation (Hypothesis 1), a targeted gene knockout study could be performed. Primary naive B-cells isolated from human donors could be subjected to CRISPR-Cas9-mediated knockout of [NBPF26](/details-gene/101060684). These knockout cells, alongside control cells, would then be cultured in vitro with stimuli (e.g., CD40L and IL-21) that promote differentiation into [plasmablasts](/details-cell/CL0000980). The impact of the knockout could be assessed by quantifying the efficiency of [plasmablast](/details-cell/CL0000980) generation via flow cytometry (using markers like CD19, CD38, and CD138), measuring immunoglobulin secretion by ELISA, and analyzing downstream transcriptional programs with RNA-sequencing. **Therapeutic Potential:** As a cytoplasmic calcium-binding protein highly expressed in antibody-producing [plasmablasts](/details-cell/CL0000980), [NBPF26](/details-gene/101060684) may represent a novel therapeutic target for B-cell-driven pathologies, such as autoimmune diseases or B-cell malignancies like multiple myeloma. Its intracellular location makes it unsuitable for antibody-based therapies but raises the possibility of developing small molecule inhibitors. A therapeutic strategy would likely focus on **inhibition** of its function to attenuate excessive B-cell activation and antibody production. The specificity of its high expression in lymphocytes could potentially minimize off-target effects compared to broad-spectrum immunosuppressants.